Latest Releases
U.S. Senator Tina Smith Joins Elizabeth Warren, Banking Committee Democrats in Pressing SEC Chair to Require Disclosure of Corporate Lobbying Expenditures
Washington, D.C. — Today, U.S. Senators Tina Smith (D – Minn.), Sherrod Brown (D-Ohio.), Jon Tester (D-Mont.) and John Fetterman (D-Pa.) signed onto a letter led by Senator Elizabeth Warren (D – Mass.) urging Gary Gensler, Chair of the U.S. Securities and Exchange Commission (SEC), to create new rules requiring public companies to disclose their spending on lobbying efforts. Public companies are not currently required to report information on the details of their lobbying to the SEC even as corporate lobbying expenditures reach record highs. “In 2022, total federal lobbying expenditures reached $4.1 billion – the highest since 2010. Amazon and Meta spent almost $20 million each to influence decision-making in Congress and across government agencies, while the U.S. Chamber of Commerce – which counts companies like JPMorgan Chase, Alphabet, and Chevron among its members – spent $79.4 million,” wrote the senators. “While these figures are staggering, they provide little insight into the interests that companies spend millions each year to advance. This lack of transparency erodes the ability of everyday investors to make informed decisions about where to invest their money – and where their money goes once they have invested.” Specifically, the senators are requesting that such rules require disclosure of lobbying strategy, the total amount of direct or indirect contributions to registered state and federal lobbyists and any material risks related to or arising from lobbying strategies and expenditures. The senators requested the SEC provide them with details on their plans to develop and issue such rules no later than
U.S. Senators Tina Smith, Tom Cotton Reintroduce Bipartisan Legislation to Boost U.S. Pharmaceutical Manufacturing
WASHINGTON, D.C. — Today, Senators Tina Smith (D-MN) and Tom Cotton (R-AR) reintroduced bipartisan legislation to reduce dependence on foreign pharmaceutical manufacturing and boost production in the U.S. The pandemic exposed our nation’s dependence on other countries for essential prescription drugs. Seventy-seven percent of key pharmaceutical ingredients come from overseas, including from China, threatening the security of the supply chain and leading to shortages of essential prescription drugs. The American Made Pharmaceuticals Act would reduce our dependence on foreign countries for pharmaceuticals by boosting production here at home. The legislation would create federal incentives to onshore manufacturing of essential medicine, while taking steps to shore up links in the supply chain. “We know that depending on foreign countries for key resources – whether it’s oil or medicine – leaves us vulnerable to global supply chain shocks and shortages,” said Sen. Smith. “This bipartisan legislation would reduce our dependence on foreign pharmaceutical manufacturing and help boost production here at home. I look forward to getting this bill across the finish line so we can relieve prescription drug shortages and build more resilient supply chains.” “The Chinese Communist Party threatened to cut off America’s access to vital drugs during the pandemic,” said Sen. Cotton. “It’s time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.” “Amneal applauds Senators Smith and Cotton on their targeted approach to increase pharmaceutical manufacturing here in the United States,” said Chirag Patel, President & Co-CEO of Amneal Pharmaceuticals. “Ensuring that
Klobuchar, Smith, Hagedorn Announce $1 Million for Infrastructure Improvements in Winona
WASHINGTON — U.S. Senators Amy Klobuchar and Tina Smith along with Representative Jim Hagedorn (MN-1) announced that the Department of Transportation (DOT) has awarded the Minnesota Department of Transportation (MnDOT) $1,000,000 in grant funding to improve infrastructure in Winona. The award will allow MnDOT to complete a project on Broadway Street, including reducing the roadway from four lanes to three lanes over 1.9 miles and adding sidewalks and pedestrian ramps to improve safety. “This funding will help pave the way for improvements in Winona’s infrastructure and make our roads and pedestrian byways safer,” Klobuchar said. “I am pleased that we were able to secure
U.S. Senator Tina Smith Helps Introduce Bipartisan Legislation to Strengthen Chronic Disease Management Effort
WASHINGTON, D.C. [01/16/20]—U.S. Senator Tina Smith helped introduce bipartisan legislation—led by Sens. John Thune (R-S.D.) and Tom Carper (D-Del.)—to lower health care costs by allowing high-deductible health plans to provide chronic disease prevention services—including insulin for diabetes—to plan enrollees before they reach their plan deductible. The Chronic Disease Management Act builds on legislation introduced last year, and it follows updated guidance issued by the U.S. Department of the Treasury last summer. In July of last year, the Internal Revenue Service issued a notice expanding its interpretation of what constitutes preventive care to include certain items and services that are prescribed to someone with certain
U.S. Senators Smith, Cardin, Van Hollen, Brown, Kaine, & Warner Successfully Fight to Make Protections for Federal Health Benefits During Government Shutdowns Law of the Land
WASHINGTON D.C. [01/14/20]—U.S. Senators Tina Smith (D-Minn.), and Sens. Ben Cardin (D-Md.), Chris Van Hollen (D-Md.), Sherrod Brown (D-Ohio), Tim Kaine (D-Va.), and Mark Warner (D-Va.) fought to secure protections for federal healthcare benefits in the event of a government shutdown, and these measures were signed into law in December as part of the National Defense Authorization Act (NDAA). Similar bipartisan legislation was introduced in the House by the late Rep. Elijah Cummings (D-Md.), who fought to include these measures in NDAA before his passing. The legislation ensures that workers who have qualifying life events are able to make the proper adjustments to their health insurance plans and continue dental and
U.S. Senator Tina Smith, Colleagues Slam FDA E-Cigarette Policy Riddled with Loopholes for Kid-Appealing Flavors
WASHINGTON, D.C. [01/13/20]–Today, U.S. Senator Tina Smith (D-Minn.)—a member of the Senate Health Committee—and 29 of her Senate colleagues sent a letter to the Food and Drug Administration (FDA) Commissioner criticizing the FDA’s decision to break the Administration’s promise to clear all non-tobacco flavored e-cigarette products from the market. On January 2, the FDA announced a weak policy that includes huge exceptions regarding menthol-flavored products and any flavored e-liquids that are not in a cartridge. This comes at a time when the youth vaping epidemic has reached an all-time high. “We are deeply disappointed with the Trump Administration’s stark reversal from its September 11, 2019 commitment to
English